Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
Clin Pharmacol Ther
.
2001 Mar;69(3):89-95.
doi: 10.1067/mcp.2001.113989.
Author
Biomarkers Definitions Working Group.
PMID:
11240971
DOI:
10.1067/mcp.2001.113989
No abstract available
Publication types
Review
MeSH terms
Animals
Biomarkers*
Clinical Trials as Topic*
Endpoint Determination / methods*
Humans
Research
Substances
Biomarkers